Leukemoid reaction as a “prognostic marker” in breast cancer and review of literature
Journal: International Archives of Integrated Medicine (IAIM) (Vol.2, No. 2)Publication Date: 2015-02-06
Authors : Hage Nobin; Abdul Wahid Ayubi; Zachariah Chowdhury; Jaya Mishra; Ojing komut;
Page : 119-122
Keywords : Leukemoid reaction; Neutrophilic leukocytosis; Prognostic marker; Breast cancer.;
Abstract
Neutrophilic leukocytosis above 50 × 109/l not involving the bone marrow, defines a leukemoid reaction (LR). Although it simulates leukemia, most of the causes are inflammatory and benign. LR has been found to be associated with malignancy which is postulated to be caused by granulocyte colony-stimulating factor (G-CSF) secreted by the tumor cells. A 50 years old woman, presented with high grade infiltrating ductal carcinoma of breast and leukocytosis (60 × 103/ cumm). After completion of MRM, the condition of neutrophilic leukocytosis subsided. After three months, total leukocyte count rose and local relapse of tumor was found. Following that wide excision was done, and the condition of leukocytosis subsided again. In this case the leukemoid reaction was a paraneoplastic reaction which can be view as a potential for prognostic marker.
Other Latest Articles
- Pyomyositis with rhino-orbital mucormycosis in type II diabetes mellitus
- The Study of Teeth eruption in Female Children of Malwa Region ? A Correlation with age
- Endonasal DCR: Our experience
- A survey on hospital patients coding accuracy in Ahvaz, Iran
- Cutaneous manifestations of diabetes mellitus in controlled and uncontrolled state
Last modified: 2015-02-23 19:10:40